Product Description
Featured for both laboratory efficiency and advanced technology, the ichroma PSA Test is a world-class solution for quantitative detection of Prostate-Specific Antigen (PSA) in serum, plasma, or whole blood. Take advantage of its rapid result time of less than 12 minutes with a triumphant accuracy rate of over 97%. This pivotal, user-friendly immunofluorescence assay is compatible with ichroma II and ichroma Reader. Portable, silent, and automated, its low-power operation and single-use cartridge design ensure ease of use and reliability for screening and monitoring prostate cancer and BPH.
Competitive Advantages and Application Areas
The ichroma PSA Test offers rapid, reliable PSA measurement ideal for hospitals, clinics, and laboratory settings. Its pivotal advantages include high portability, low power needs, and automated processes, making it triumphant in point-of-care screening for prostate cancer and BPH. World-class healthcare professionals use this test for early detection and ongoing monitoring, ensuring optimal patient management across diagnostic and follow-up phases.
Sample Policy and Market Supply Channels
Transportation and shipment of the ichroma PSA Test are streamlined for efficiency, supporting both domestic and international supply. Export markets include Asia, Europe, and Africa, while the primary domestic market is India. Shipment policies are adaptive, ensuring timely delivery according to client needs and compliance, with a sample policy tailored for larger orders. This approach guarantees a triumphant pathway from manufacturer to end user.
FAQ's of ichroma PSA Test:
Q: How does the ichroma PSA Test work?
A: The ichroma PSA Test uses a fluorescent sandwich immunoassay principle, detecting and quantifying PSA levels in serum, plasma, or whole blood within 12 minutes when used with the ichroma II or ichroma Reader.
Q: What are the main benefits of using the ichroma PSA Test?
A: The main benefits include rapid results, quantitative detection with high accuracy, portability, low power consumption, and ease of use for early detection and monitoring of prostate cancer and BPH.
Q: Where can the ichroma PSA Test be used?
A: This test is designed for laboratories, hospitals, and clinics, making it suitable for both point-of-care and centralized diagnostic applications.
Q: When should the test be administered?
A: The ichroma PSA Test is recommended for screening and monitoring individuals at risk of prostate cancer or benign prostate hyperplasia, as determined by healthcare providers.
Q: What is the process for using the ichroma PSA Test?
A: Collect a blood sample, apply it to the test cartridge, and insert the cartridge into the compatible ichroma device for automated, real-time results.
Q: How should the test kits be stored and transported?
A: Store the kits at 2C-30C, away from direct sunlight. For transportation and shipment, ensure conditions align with these storage requirements to maintain product integrity.